Herpes Simplex Virus Type 2 (HSV-2) in Pregnancy: Detection and Management
Yes, it is possible for a pregnant woman to have herpes simplex virus type 2 (HSV-2) infection without it showing up in a lab test. This occurs due to limitations in testing sensitivity and the nature of viral shedding patterns 1.
Why HSV-2 May Not Be Detected During Pregnancy
- Intermittent viral shedding: HSV-2 can remain dormant in nerve ganglia and shed intermittently, meaning the virus may not be actively replicating at the time of testing 1
- Test limitations: No test is 100% sensitive, and false negatives can occur
- Timing of infection: Recently acquired infections may not have produced sufficient antibodies for detection
- Asymptomatic infections: Up to 80% of HSV-2 infections are asymptomatic, making clinical diagnosis challenging 1
Testing Considerations During Pregnancy
- Type-specific serologic tests are recommended for diagnosing HSV-2 in pregnancy when clinical symptoms are present 1
- Routine screening for HSV serostatus during pregnancy is not recommended by the American College of Obstetrics and Gynecology due to lack of evidence for cost-effectiveness 1, 2
- Viral cultures during pregnancy do not reliably predict viral shedding at delivery and are not indicated routinely 1
Risks of HSV-2 in Pregnancy
- Neonatal transmission risk is highest (30-50%) when a mother acquires genital herpes near the time of delivery 1
- Risk is lower (approximately 3%) among women with recurrent herpes at term or who acquire HSV during the first half of pregnancy 1
- Maternal genital herpes is a risk factor for perinatal mother-to-child HIV transmission in HIV-positive women 1
Management Recommendations
For Women with Known HSV-2 Infection:
Suppressive therapy with acyclovir (400 mg TID) or valacyclovir (500 mg BID) starting at 36 weeks' gestation reduces:
- Viral shedding
- Recurrences
- Need for cesarean deliveries 1
Cesarean delivery is recommended for women with:
- Genital herpes prodrome
- Visible HSV genital lesions at the onset of labor 1
Acyclovir is the antiviral drug with the most reported experience in pregnancy and appears to be safe; therefore, it is the first choice for therapy of HSV infections in pregnancy 1
For Women with Suspected New HSV-2 Infection:
- Immediate testing with type-specific serologic tests and viral culture if lesions are present
- Counseling about the high risk of transmission if infection occurs in late pregnancy
- Avoidance of unprotected genital and oral sexual contact during late pregnancy, especially for susceptible women 1
Important Considerations
- Breastfeeding should not be discouraged in HSV-infected mothers unless they have cracked nipples and detectable HSV DNA 1
- Invasive fetal monitoring can increase the risk of neonatal herpes and should only be used for defined obstetrical indications 3
- Safety of antivirals: Acyclovir has been extensively studied in pregnancy with no increased risk of major birth defects compared to the general population 1, 4
Prevention of Neonatal Herpes
- Examine all women at the onset of labor for symptoms of genital herpes
- Cesarean delivery significantly reduces HSV transmission rates among women with active HSV infection (1.2% vs 7.7% with vaginal delivery) 5
- Avoid triggers that may cause recurrence near term (stress, UV radiation, local trauma) 4
Remember that the highest risk of neonatal infection occurs when the mother acquires genital HSV in the third trimester, making prevention of new infections during pregnancy a critical goal 3.